BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31948794)

  • 1. Psychological distress in patients under surveillance for intraductal papillary mucinous neoplasms of the pancreas: The "Sword of Damocles" effect calls for an integrated medical and psychological approach a prospective analysis.
    Marinelli V; Secchettin E; Andrianello S; Moretti C; Donvito S; Marchegiani G; Esposito A; Casetti L; Salvia R
    Pancreatology; 2020 Apr; 20(3):505-510. PubMed ID: 31948794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilocular Cyst of Type 1 Autoimmune Pancreatitis Masquerading as Cancerization of Intraductal Papillary Mucinous Neoplasm.
    Kaneko J; Matsubayashi H; Satoh T; Sato J; Takinami M; Ishiwatari H; Uesaka K; Abe M; Sasaki K; Ono H
    Intern Med; 2020 Jan; 59(2):199-204. PubMed ID: 31484912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements.
    Dbouk M; Brewer Gutierrez OI; Lennon AM; Chuidian M; Shin EJ; Kamel IR; Fishman EK; He J; Burkhart RA; Wolfgang CL; Hruban RH; Goggins MG; Canto MI
    Pancreatology; 2021 Apr; 21(3):613-621. PubMed ID: 33593706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyst location and presence of high grade dysplasia or invasive cancer in intraductal papillary mucinous neoplasms of the pancreas: a seven institution study from the central pancreas consortium.
    Kerlakian S; Dhar VK; Abbott DE; Kooby DA; Merchant NB; Kim HJ; Martin RC; Scoggins CR; Bentrem DJ; Weber SM; Maithel SK; Ahmad SA; Patel SH
    HPB (Oxford); 2019 Apr; 21(4):482-488. PubMed ID: 30361110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraductal papillary mucinous neoplasm of pancreas].
    Panteleev VI; Gorin DS; Kaldarov AR; Kriger AG
    Khirurgiia (Mosk); 2019; (11):81-87. PubMed ID: 31714535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of age in pancreatic intraductal papillary mucinous neoplasms of the pancreas: Same risk of death but different implications for management.
    Marchegiani G; Andrianello S; Perri G; Pollini T; Caravati A; Secchettin E; Malleo G; Bassi C; Salvia R
    Dig Liver Dis; 2018 Dec; 50(12):1327-1333. PubMed ID: 29941281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Management of Main Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas.
    Dal Borgo C; Perri G; Borin A; Marchegiani G; Salvia R; Bassi C
    Dig Surg; 2019; 36(2):104-110. PubMed ID: 29421807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of Deep Learning Analysis for the Diagnosis of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Kuwahara T; Hara K; Mizuno N; Okuno N; Matsumoto S; Obata M; Kurita Y; Koda H; Toriyama K; Onishi S; Ishihara M; Tanaka T; Tajika M; Niwa Y
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31117111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Undifferentiated Solitary Mucinous Cystic Lesion of the Pancreas: A Clinical Dilemma.
    Roch AM; Bigelow K; Schmidt CM; Carr RA; Jester AL; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2017 Apr; 224(4):717-723. PubMed ID: 28126546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Mimicker of Intraductal Papillary Mucinous Carcinoma of the Pancreas.
    Yoshida A; Yamao K; Watanabe T
    Gastroenterology; 2021 Nov; 161(5):e8-e11. PubMed ID: 33812893
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
    Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms.
    Yoon WJ; Ryu JK; Lee JK; Woo SM; Lee SH; Park JK; Kim YT; Yoon YB
    Ann Surg Oncol; 2008 Nov; 15(11):3193-8. PubMed ID: 18784959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination of intraductal papillary mucinous neoplasm with other cystic pancreatic tumors].
    Panteleev VI; Kaldarov AR; Gorin DS; Kriger AG
    Khirurgiia (Mosk); 2021; (2):80-83. PubMed ID: 33570359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms.
    Mukewar S; de Pretis N; Aryal-Khanal A; Ahmed N; Sah R; Enders F; Larson JJ; Levy MJ; Takahashi N; Topazian M; Pearson R; Vege SS; Chari ST
    Gut; 2017 Oct; 66(10):1811-1817. PubMed ID: 27390303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of main pancreatic duct dilatation in IPMN undergoing surveillance.
    Marchegiani G; Andrianello S; Morbin G; Secchettin E; D'Onofrio M; De Robertis R; Malleo G; Bassi C; Salvia R
    Br J Surg; 2018 Dec; 105(13):1825-1834. PubMed ID: 30106195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?
    Marchegiani G; Andrianello S; Pollini T; Caravati A; Biancotto M; Secchettin E; Bonamini D; Malleo G; Bassi C; Salvia R
    Am J Gastroenterol; 2019 Oct; 114(10):1678-1684. PubMed ID: 31449158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical strategy for intraductal papillary mucinous neoplasms of the pancreas.
    Hirono S; Yamaue H
    Surg Today; 2020 Jan; 50(1):50-55. PubMed ID: 31807871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
    Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
    O'Neill RS; Emmanuel S; Williams D; Stoita A
    World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
    Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
    J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.